Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 329 of 1,261
  1. US 11058670

    Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

    Corcept Therapeutics Incorporated · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  2. US 11060144

    Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype

    VANDA PHARMACEUTICALS INC. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  3. US 11061094

    Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)

    The Regents of the University of California · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  4. US 11060110

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  5. US 11060091

    Hepatitis B virus (HBV) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  6. US 11060087

    Synthetic promoters for high throughput screening and gene modulation

    The Regents of the University of California · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  7. US 11059906

    Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma

    Takeda Pharmaceutical Company Limited · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  8. US 11059880

    Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  9. US 11059878

    Therapeutic targeting of SET1B/compass pathway for treating cancers

    Northwestern University · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  10. US 11059830

    Compounds that participate in cooperative binding and uses thereof

    Revolution Medicines, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  11. US 11059817

    Potent antiviral pyrazolopyridine compounds

    The Regents of the University of California · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  12. US 11059814

    Kinase inhibitors and methods for making and using

    Rigel Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  13. US 11059826

    Pteridinone compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  14. US 11059796

    Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  15. US 11059808

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  16. US 11058770

    Ultrastable antibody ionic liquids

    United States of America as represented by the Secretary of the Air Force · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  17. US 11058766

    Universal vaccine platform

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  18. US 11058728

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  19. US 11058664

    In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors

    Provectus Pharmatech, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  20. US 11058709

    Methods of treating breast cancer

    Ionis Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  21. US 11058678

    Substituted heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  22. US 11058704

    Inhibitors of adenosine 5′-nucleotidase

    Arcus Biosciences, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  23. US 11058671

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    RedHill Biopharma Ltd. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  24. US 11058729

    Exosomes and miRNA to treat glaucoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.